Neupro 3 mg/24 hours transdermal system Images
Generic Name: rotigotine
This medication has been identified as Neupro 3 mg/24 hours transdermal system. It is supplied by UCB, Inc.
Neupro is used in the treatment of Restless Legs Syndrome; Parkinson's Disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Neupro 3 mg/24 hours transdermal system is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Neupro
- Generic Name
- rotigotine
- Strength
- 3 mg/24 hours transdermal system
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- UCB, Inc.
- National Drug Code (NDC)
- 50474-0803
More about Neupro (rotigotine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (70)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: dopaminergic antiparkinsonism agents
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
